PlainRecalls
FDA Drug Moderate Class II Terminated

Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. Made in India

Reported: June 5, 2013 Initiated: April 22, 2013 #D-500-2013

Product Description

Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. Made in India

Reason for Recall

Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..

Details

Units Affected
3,048 bottles
Distribution
Nationwide
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. Made in India. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 3,048 bottles.
Why was this product recalled?
Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..
Which agency issued this recall?
This recall was issued by the FDA Drug on June 5, 2013. Severity: Moderate. Recall number: D-500-2013.